First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jeff Longmate Edward Garmey Mark E. Davis |
| Publication date | February 9, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |